Tristel | Sustainability Performance
Tristel develops and delivers infection prevention products and systems. The company primarily serves healthcare environments, providing solutions designed to achieve high levels of cleanliness and safety standards.
1993
United Kingdom
201 - 500 employees
Medical Device
$25M - 100M in revenue
$1M - 10M in profitability
Sustainability Ranking & Industry Benchmark
#5377
Overall#795
in United Kingdom#74
in Medical DeviceSustainability Maturity
Sustainability Intent
Overview
Governance
TargetsESG scores and ExclusionsFinancial Data
Business performanceCapital & innovationAnalyst projections
Market cap
Revenue
Controversy level
- Tristel's medical device decontamination products faced regulatory review regarding efficacy claims.
Market cap
Revenue
EBITDA
Operating margin
Revenue & EBITDA
$60.6MFY2025 revenue
Total Annual
Revenue & EBITDA
($ B)
Annual revenue
EBITDA
3 year change
Margin trends
Margin as % of revenue
Gross margin
Operating margin
Net margin
Powered by illuminem
Free cashflow
Capex
Debt/equity ratio
Analyst revenue estimates & actuals
Analyst consensus vs actuals
($ B)
Actual revenue
Consensus estimates
Estimate only
0.0
▲ 1.5%
0.1
▼ 2.1%
0.1
▼ 1.1%
0.1
2030Powered by illuminem
Sustainability targets and commitments
Reveal data for 1 credit
| Target | Year | Value | Scope | Baseline |
|---|
Progress against targets
Environmental policy coverage
Carbon reduction policy
Not available
Human rights policy
Not available
Recycling policy
Not available
Workplace health & safety policy
Not available
38%
Independent Directors
3 out of 8 incl. management
Overall score
0
Environment
0
Social
0
Governance
0
Exclusion screening
Adult content
Not available
Alcoholic
Not available
Animal testing
Not available
Firearms
Not available
Tobacco
Not available
Gambling
Not available
Nuclear
Not available
